Stable luciferase expression does not alter immunologic or in vivo growth properties of GL261 murine glioma cells

Oligodendrocyte Progenitor Cells Promote Neovascularization in Glioma by Disrupting the Blood-Brain Barrier

(2013) Y. Huang et al.   CANCER RESEARCH

Cytokines associated with toxicity in the treatment of recurrent glioblastoma with aflibercept

(2013) Nicole Shonka et al.   Targeted Oncology

Soluble factors secreted by glioblastoma cell lines facilitate recruitment, survival, and expansion of regulatory T cells: implications for immunotherapy

(2012) C. A. Crane et al.   NEURO-ONCOLOGY

BMP2 sensitizes glioblastoma stem-like cells to Temozolomide by affecting HIF-1α stability and MGMT expression

(2012) L Persano et al.   Cell Death & Disease

Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group

(2011) M. Dowsett et al.   JNCI-Journal of the National Cancer Institute

Establishing Intracranial Brain Tumor Xenografts With Subsequent Analysis of Tumor Growth and Response to Therapy using Bioluminescence Imaging

(2010) Tomoko Ozawa et al.   Jove-Journal of Visualized Experiments

Site-specific anti-tumor immunity: Differences in DC function, TGF-β production and numbers of intratumoral Foxp3+ Treg

(2009) Gregoire Biollaz et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Investigation of immunosuppressive mechanisms in a mouse glioma model

(2009) Alexander Ksendzovsky et al.   JOURNAL OF NEURO-ONCOLOGY

Immunological considerations of modern animal models of malignant primary brain tumors

(2009) Michael E Sughrue et al.   Journal of Translational Medicine